Table 5.

Jatropha mollissima’s effect on AST and ALT of SVP-treated rats

Groups	Observation (day)
	0	7th	21st
AST (u/L)
Control	81 ± 6.1	75 ± 4.3	69 ± 5.1
SVP	63 ± 5.5	180 ± 11*	171 ± 6.4*
SVP + Jma	71 ± 7.8	137 ± 11&	140 ± 5.6&
SVP + Jmb	69 ± 8.4	25 ± 12#	116 ± 6.0#
ALT (u/L)
Control	30 ± 4.3	41 ± 6.2	35 ± 3.5
SVP	28 ± 3.5	98 ± 4.9*	97 ± 8.9*
SVP + Jma	23 ± 3.6	74 ± 6.3&	70 ± 4.2&
SVP + Jmb	30 ± 3.0	60 ± 6.9#	58 ± 6.0#

Mean ± SEM (n=6), where SVP is sodium valproate (500 mg/kg i.p), SVP + Jm^a is sodium valproate + Jatropha mollissima extract (200 mg/kg/21 days), SVP + Jm^b is sodium valproate + Jatropha mollissima extract (400 mg/kg/21 days).

^*Indicates P < 0.05 vs normal.

^&P < 0.05 shows vs SVP.

^#P < 0.05 Indicates SVP + Jatropha mollissima on corresponding days.